CBD Life Sciences Inc. $CBDL PURSUES EXPANSION INTO MEDICAL MARIJUANA INDUSTRY AND ADVANCES CORPORATE GROWTH AND SEC REPORTING INITIATIVES


SCOTTSDALE, AZ — November 17, 2026 — CBD Life Sciences, Inc. (OTC: CBDL) today announced that it is actively pursuing opportunities to enter the medical marijuana industry as part of its broader corporate growth and business development strategy.
The Company is evaluating potential opportunities within the medical cannabis sector, including strategic partnerships, business acquisitions, licensing opportunities, and other potential business relationships that could support its entry into this industry.
In addition to exploring the medical marijuana sector, CBDL continues to pursue its longer-term corporate objectives, including efforts toward full SEC reporting status, investor outreach, and strategic business development.
Pursuing Entry Into the Medical Marijuana Industry
CBD Life Sciences believes the medical cannabis industry represents a potential area of strategic business development and expansion.
The Company is actively exploring opportunities to establish a presence in the medical marijuana marketplace. These efforts may include evaluating licensed operators, strategic partnerships, acquisitions, distribution relationships, and other opportunities that could provide a pathway into the industry.
Management intends to evaluate opportunities based on their business potential, regulatory requirements, operational considerations, and alignment with the Company's long-term objectives.
Any entry into the medical marijuana industry would be subject to applicable state and federal laws, licensing requirements, regulatory approvals, and other necessary authorizations.
Advancing Toward Full SEC Reporting Status
CBD Life Sciences, Inc. is pursuing a transition toward becoming a fully SEC-reporting company as part of its long-term corporate growth and capital markets strategy.
These initiatives are intended to advance corporate transparency, strengthen the Company's reporting framework, and expand its opportunities within the public capital markets.
The Company believes pursuing full SEC reporting status represents an important step in its long-term development and commitment to providing shareholders and the investment community with greater corporate transparency.
Investor and Strategic Capital Initiatives
CBD Life Sciences continues to explore investor relationships and strategic capital opportunities to support its corporate objectives and potential business expansion.
The Company is interested in connecting with qualified investors, private investment groups, strategic funding partners, and other financial relationships that may help support its plans.
As CBDL evaluates opportunities in the medical marijuana industry and advances its other business initiatives, management believes that establishing appropriate financial and strategic relationships will be an important component of its future development.
Continued Corporate Growth and Expansion
CBDL remains focused on developing its existing business operations while identifying additional opportunities across the CBD, wellness, and medical cannabis industries.
The Company intends to continue evaluating opportunities that may strengthen its business platform, expand its market presence, and support its long-term corporate objectives.
Management Commentary
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated:
"We believe CBDL has an opportunity to pursue an exciting new chapter of corporate growth. We are actively exploring opportunities to enter the medical marijuana industry while continuing to develop our existing business operations and pursue additional strategic initiatives.
Our efforts toward full SEC reporting status reflect our commitment to strengthening the Company's corporate structure and pursuing our long-term capital markets objectives.
We are focused on identifying the right opportunities, building strategic relationships, and positioning CBDL for its next phase of development."
Looking Ahead
CBD Life Sciences intends to continue evaluating medical cannabis business opportunities, advancing its corporate reporting initiatives, developing strategic relationships, and pursuing opportunities that may contribute to the Company's long-term growth.
The Company looks forward to providing shareholders and the investment community with updates as material developments occur.
About CBD Life Sciences, Inc.
CBD Life Sciences, Inc. (OTC: CBDL) is a publicly traded company headquartered in Scottsdale, Arizona. The Company's business operations include The CBD Vault, a CBD and wellness business. CBDL continues to evaluate opportunities for corporate expansion and potential entry into the medical marijuana industry.
Company Contact Information:
Website: www.thecbdvault.com
Email: cbdvaultaz@gmail.com
Store Phone: +1 (480) 209-1720
Instagram: @thecbdvault
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include expectations regarding potential entry into the medical marijuana industry, business acquisitions, partnerships, licensing opportunities, SEC reporting initiatives, investor relationships, financing opportunities, and future corporate development.
These statements are subject to risks and uncertainties, and actual results may differ materially. The Company has not represented that it has obtained any medical marijuana licenses or regulatory approvals unless specifically disclosed. Any potential business activity in the medical cannabis industry would be subject to applicable laws and regulatory requirements. The Company undertakes no obligation to update forward-looking statements except as required by law.



Comments